title: Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem.
abstract: The objective of this study was to evaluate the return of fertility in women who used Cyclofem as a contraceptive method during the introductory studies conducted in Brazil, Chile, Colombia, and Peru. From these four cohorts, 101 women were eligible for the study. Thirty-one were not included in the study either because they refused to be interviewed, had initiated another contraceptive method the month after discontinuation, or were unable to be contacted. A total of 70 women were included in the study. Our results showed that the return to fertility rate after the discontinuation of Cyclofem was 1.4 per 100 women at the end of the first month and reached 82.9 at one year. More than 50% were pregnant at 6 months. Fifty-one (94.4%) pregnancies ended in a live birth, two were spontaneous first trimester abortions, and one was a hydatidiform mole. Return of fertility was not related to the woman's age at the time of discontinuation, her weight, or the number of Cyclofem injections. In conclusion, fertility is restored by 1 month following Cyclofem discontinuation. Users and potential users should be counseled regarding the rapid return of fertility after discontinuing this method of contraception.
authors.affiliation: Departamento de Tocoginecologia, Universidade Estadual de Campinas, Brasil.
authors.forename: L
authors.initials: L
authors.lastname: Bahamondes
authors.forename: P
authors.initials: P
authors.lastname: Lavín
authors.forename: G
authors.initials: G
authors.lastname: Ojeda
authors.forename: C
authors.initials: C
authors.lastname: Petta
authors.forename: J
authors.initials: J
authors.lastname: Diaz
authors.forename: E
authors.initials: E
authors.lastname: Maradiegue
authors.forename: I
authors.initials: I
authors.lastname: Monteiro
mesh_terms: D000328:Adult; D015331:Cohort Studies; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage; D004338:Drug Combinations; D004958:Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D005298:Fertility; D006801:Humans; D007267:Injections; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage*; D011247:Pregnancy; D013997:Time Factors
chemical_list: D003271:Contraceptive Agents, Female; D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; D004958:Estradiol; C034528:CycloProvera; D017258:Medroxyprogesterone Acetate